Christopher Koh

Multidisciplinary Collaborative Clinical Research, Protocol Navigation, Monitoring Compliance, and Other Clinical Services in NIDDK Program Area Diseases

National Institute of Diabetes and Digestive and Kidney Diseases · ZID

Contact PI · $8.6M · National Institute of Diabetes and Digestive and Kidney Diseases

Management and Treatment of Chronic Delta Hepatitis Infection and Other Liver Diseases

National Institute of Diabetes and Digestive and Kidney Diseases · ZIA

Contact PI · $2.8M · National Institute of Diabetes and Digestive and Kidney Diseases

Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis

Principal investigator · Withdrawn · Phase 2

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon

Principal investigator · Completed · Phase 2

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C

Principal investigator · Completed · Phase 1, Phase 2

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Diagnosis and Treatment of Patients With Cystic Fibrosis

Principal investigator · Terminated

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)